Equity Overview
Price & Market Data
Price: $0.421
Daily Change: -$0.0298 / 7.09%
Range: $0.414 - $0.46
Market Cap: $28,183,522
Volume: 391,257
Performance Metrics
1 Week: 21.25%
1 Month: -11.13%
3 Months: -56.34%
6 Months: -81.22%
1 Year: -85.03%
YTD: -60.32%
Company Details
Employees: 115
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Generation Bio Co., a biotechnology company, discovers, develops, and commercializes redosable therapeutics that reprogram T cells in vivo to reduce or eliminate the production and persistence of autoreactive T cells. It develops cell-targeted lipid nanoparticles (ctLNP) to selectively deliver small interfering RNA (siRNA) T cells to selectively delivery, intracellular, and genetically precise mechanism of target engagement could unlock a series of high-value historically undruggable disease-driving genes in autoimmunity. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.